Comorbidities, Associated Diseases, and Risk Assessment in COVID‐19—A Systematic Review
Andreea Fitero, Simona Bungău, Delia Mirela Ţiţ, Laura Endres, Shamim Ahmad Khan, Alexa Florina Bungău, Ioana Romanul, Cosmin Mihai Vesa, Andrei-Flavius Radu, Alexandra Georgiana Tarce, Mihaela Alexandra Bogdan, Aurelia Cristina Nechifor, Nicoleta Negruţ
Abstract
It is considered that COVID-19's pandemic expansion is responsible for the particular increase in deaths, especially among the population with comorbidities. The health system is often overwhelmed by the large number of cases of patients addressing it, by the regional limitation of funds, and by the gravity of cases at subjects suffering from this pathology. Several associated conditions including diabetes, cardiovascular illnesses, obesity, persistent lung condition, neurodegenerative diseases, etc., increase the mortality risk and hospitalization of subjects suffering from COVID-19. The rapid identification of patients with increased risk of death from the SARS-CoV-2 virus, the stratification in accordance with the risk and the allocation of human, financial, and logistical resources in proportion must be a priority for health systems worldwide.